Cargando…
Enhanced NSAIDs Solubility in Drug–Drug Formulations with Ciprofloxacin †
Drug–drug salts are a kind of pharmaceutical multicomponent solid in which the two co-existing components are active pharmaceutical ingredients (APIs) in their ionized forms. This novel approach has attracted great interest in the pharmaceutical industry since it not only allows concomitant formulat...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9964002/ https://www.ncbi.nlm.nih.gov/pubmed/36834716 http://dx.doi.org/10.3390/ijms24043305 |
_version_ | 1784896395087446016 |
---|---|
author | Acebedo-Martínez, Francisco Javier Domínguez-Martín, Alicia Alarcón-Payer, Carolina Sevillano-Páez, Alejandro Verdugo-Escamilla, Cristóbal González-Pérez, Josefa María Martínez-Checa, Fernando Choquesillo-Lazarte, Duane |
author_facet | Acebedo-Martínez, Francisco Javier Domínguez-Martín, Alicia Alarcón-Payer, Carolina Sevillano-Páez, Alejandro Verdugo-Escamilla, Cristóbal González-Pérez, Josefa María Martínez-Checa, Fernando Choquesillo-Lazarte, Duane |
author_sort | Acebedo-Martínez, Francisco Javier |
collection | PubMed |
description | Drug–drug salts are a kind of pharmaceutical multicomponent solid in which the two co-existing components are active pharmaceutical ingredients (APIs) in their ionized forms. This novel approach has attracted great interest in the pharmaceutical industry since it not only allows concomitant formulations but also has proved potential to improve the pharmacokinetics of the involved APIs. This is especially interesting for those APIs that have relevant dose-dependent secondary effects, such as non-steroidal anti-inflammatory drugs (NSAIDs). In this work, six multidrug salts involving six different NSAIDs and the antibiotic ciprofloxacin are reported. The novel solids were synthesized using mechanochemical methods and comprehensively characterized in the solid state. Moreover, solubility and stability studies, as well as bacterial inhibition assays, were performed. Our results suggest that our drug–drug formulations enhanced the solubility of NSAIDs without affecting the antibiotic efficacy. |
format | Online Article Text |
id | pubmed-9964002 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-99640022023-02-26 Enhanced NSAIDs Solubility in Drug–Drug Formulations with Ciprofloxacin † Acebedo-Martínez, Francisco Javier Domínguez-Martín, Alicia Alarcón-Payer, Carolina Sevillano-Páez, Alejandro Verdugo-Escamilla, Cristóbal González-Pérez, Josefa María Martínez-Checa, Fernando Choquesillo-Lazarte, Duane Int J Mol Sci Article Drug–drug salts are a kind of pharmaceutical multicomponent solid in which the two co-existing components are active pharmaceutical ingredients (APIs) in their ionized forms. This novel approach has attracted great interest in the pharmaceutical industry since it not only allows concomitant formulations but also has proved potential to improve the pharmacokinetics of the involved APIs. This is especially interesting for those APIs that have relevant dose-dependent secondary effects, such as non-steroidal anti-inflammatory drugs (NSAIDs). In this work, six multidrug salts involving six different NSAIDs and the antibiotic ciprofloxacin are reported. The novel solids were synthesized using mechanochemical methods and comprehensively characterized in the solid state. Moreover, solubility and stability studies, as well as bacterial inhibition assays, were performed. Our results suggest that our drug–drug formulations enhanced the solubility of NSAIDs without affecting the antibiotic efficacy. MDPI 2023-02-07 /pmc/articles/PMC9964002/ /pubmed/36834716 http://dx.doi.org/10.3390/ijms24043305 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Acebedo-Martínez, Francisco Javier Domínguez-Martín, Alicia Alarcón-Payer, Carolina Sevillano-Páez, Alejandro Verdugo-Escamilla, Cristóbal González-Pérez, Josefa María Martínez-Checa, Fernando Choquesillo-Lazarte, Duane Enhanced NSAIDs Solubility in Drug–Drug Formulations with Ciprofloxacin † |
title | Enhanced NSAIDs Solubility in Drug–Drug Formulations with Ciprofloxacin † |
title_full | Enhanced NSAIDs Solubility in Drug–Drug Formulations with Ciprofloxacin † |
title_fullStr | Enhanced NSAIDs Solubility in Drug–Drug Formulations with Ciprofloxacin † |
title_full_unstemmed | Enhanced NSAIDs Solubility in Drug–Drug Formulations with Ciprofloxacin † |
title_short | Enhanced NSAIDs Solubility in Drug–Drug Formulations with Ciprofloxacin † |
title_sort | enhanced nsaids solubility in drug–drug formulations with ciprofloxacin † |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9964002/ https://www.ncbi.nlm.nih.gov/pubmed/36834716 http://dx.doi.org/10.3390/ijms24043305 |
work_keys_str_mv | AT acebedomartinezfranciscojavier enhancednsaidssolubilityindrugdrugformulationswithciprofloxacin AT dominguezmartinalicia enhancednsaidssolubilityindrugdrugformulationswithciprofloxacin AT alarconpayercarolina enhancednsaidssolubilityindrugdrugformulationswithciprofloxacin AT sevillanopaezalejandro enhancednsaidssolubilityindrugdrugformulationswithciprofloxacin AT verdugoescamillacristobal enhancednsaidssolubilityindrugdrugformulationswithciprofloxacin AT gonzalezperezjosefamaria enhancednsaidssolubilityindrugdrugformulationswithciprofloxacin AT martinezchecafernando enhancednsaidssolubilityindrugdrugformulationswithciprofloxacin AT choquesillolazarteduane enhancednsaidssolubilityindrugdrugformulationswithciprofloxacin |